Literature DB >> 16159931

Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease.

Ariel Rokach1, Arthur Pollak, Laura Rosen, Yechiel Friedlander, Anat Blumenfeld, Luba Reznik, Rivka Dresner-Pollak.   

Abstract

CONTEXT: Sequence variants in the estrogen receptor alpha gene (ESR1) may alter the atheroprotective effects of estrogens, and be associated with the severity of coronary artery disease (CAD).
OBJECTIVE: This study seeks to investigate the association between the ESR1 haplotype created by the c.454-397 T>C and c.454-351 A>G polymorphisms, the length of the (TA)n repeats, and the angiographic extent of CAD.
DESIGN: Consecutive subjects with age younger than or equal to 55 yr who had undergone coronary angiography between November 2003 and January 2004 were included in the study.
SETTING: The study was conducted in a referral center. PATIENTS: One hundred five subjects with age younger than or equal to 55 yr (87 males, 18 females) participated in the study. MAIN OUTCOME MEASURES: The angiographic extent of CAD was graded by number of: 1) major coronary vessels with more than 50% narrowing (NMCV); 2) narrowed major coronary vessels and/or their second-order branch (NCV); and 3) coronary segments with any narrowing (NN). Analysis of covariance was used to test the effect of haplotype and (TA)n length on the angiographic extent of CAD with gender and number of CAD risk factors (hyperlipidemia, diabetes, hypertension, obesity, smoking, and family history of CAD) as covariates.
RESULTS: The ESR1 haplotype c.454-397C and c.454-351G was associated with NCV and NN (P = 0.008 and 0.02, respectively). Carriers of two copies of haplotype C-G had a higher number of NCV compared with subjects with one or no copies combined (3.5 +/- 2.2 vs. 2.3 +/- 1.9, P = 0.012, respectively). A longer (TA)n repeat was associated with NCV (P = 0.04).
CONCLUSIONS: The ESR1 c.454-397C and c.454-351G haplotype and longer (TA)n repeats are associated with the extent of CAD in young subjects, independent of the known CAD risk factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159931     DOI: 10.1210/jc.2005-0236

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.

Authors:  Worapaka Manosroi; Jia Wei Tan; Chevon M Rariy; Bei Sun; Mark O Goodarzi; Aditi R Saxena; Jonathan S Williams; Luminita H Pojoga; Jessica Lasky-Su; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny H Xiang; Willa A Hsueh; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Ellen W Seely
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

2.  Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

Authors:  Jacques Rossouw; Paul Bray; Jingmin Liu; Charles Kooperberg; Judith Hsia; Cora Lewis; Mary Cushman; Denise Bonds; Susan Hendrix; George Papanicolaou; Timothy Howard; David Herrington
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-24       Impact factor: 8.311

3.  Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels.

Authors:  Inga Peter; Alyson Kelley-Hedgepeth; Caroline S Fox; L Adrienne Cupples; Gordon S Huggins; David E Housman; Richard H Karas; Michael E Mendelsohn; Daniel Levy; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

Review 4.  Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies.

Authors:  Jie Ding; Hui Xu; Xiang Yin; Fu-rong Zhang; Xiao-ping Pan; Yi-an Gu; Jun-zhu Chen; Xiao-gang Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

5.  Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder.

Authors:  Margarete Cristiane Ribeiro-Dasilva; Sérgio Roberto Peres Line; Maria Cristina Leme Godoy dos Santos; Mariana Trevisani Arthuri; Wei Hou; Roger Benton Fillingim; Célia Marisa Rizzatti Barbosa
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

6.  Neuroendocrine stress response is moderated by sex and sex hormone receptor polymorphisms.

Authors:  W J Hastings; A M Chang; R P Ebstein; I Shalev
Journal:  Horm Behav       Date:  2018-10-11       Impact factor: 3.587

7.  Association between arterial stiffness and variations in oestrogen-related genes.

Authors:  I Peter; A Kelley-Hedgepeth; G S Huggins; D E Housman; M E Mendelsohn; J A Vita; R S Vasan; D Levy; E J Benjamin; G F Mitchell
Journal:  J Hum Hypertens       Date:  2009-02-05       Impact factor: 3.012

8.  Lack of association of estrogen receptor alpha gene polymorphisms with cardiorespiratory and metabolic variables in young women.

Authors:  Ana Cristina Rebelo; Rozangela Verlengia; Vandeni Kunz; Nayara Tamburus; Alvaro Cerda; Rosario Hirata; Mario Hirata; Ester Silva
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

9.  A study for association and interaction analysis to metabolic syndrome and the ESR1 gene on cardiovascular autonomic neuropathy in a Chinese Han population.

Authors:  Fangfang Zeng; Linuo Zhou; Zihui Tang
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.